학술논문

Survivin in brain tumors: an attractive target for immunotherapy
Document Type
Article
Source
Journal of Neuro-Oncology; August 2003, Vol. 64 Issue: 1-2 p71-76, 6p
Subject
Language
ISSN
0167594X; 15737373
Abstract
Survivin, a member of the inhibitor of apoptosis proteins gene family, was recently shown to be expressed by tumors originating from different cell lineages. There are also cumulative evidences that spontaneous immune response against survivin derived epitopes may occur. Here, using RT-PCR, Western-blot analysis and immunohistochemistry, we show that survivin is widely expressed by gliomas, meningiomas and schwannomas, bothin vitroandin vivo. These data indicate that survivin may serve as an attractive target for immunotherapies designed for brain tumors.